>

SpCas9 sgRNA stem loop (medium)

Q: Can I use the SpCas9 sgRNA stem loop (medium) icon in a BioRender figure or scientific illustration?

Yes — the SpCas9 sgRNA stem loop (medium) is fully integrated into BioRender's drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you're building from scratch or starting with a BioRender template.

Q: Can I export figures that include the SpCas9 sgRNA stem loop (medium) icon for publication or presentations?

Yes — figures containing the SpCas9 sgRNA stem loop (medium) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

SpCas9 sgRNA stem loop (medium) - Editable icon of SpCas9 sgRNA stem loop (medium)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4493/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4493/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4492/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4492/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4491/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4491/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4490/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4490/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c448f/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c448f/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c448e/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c448e/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c448d/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c448d/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c448c/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c448c/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c448b/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c448b/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c448a/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c448a/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4489/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4489/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4488/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4488/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4487/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4487/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4486/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4486/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4485/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4485/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4484/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4484/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4483/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4483/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4482/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4482/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4481/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4481/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4480/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4480/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c447f/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c447f/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c447e/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c447e/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c447d/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c447d/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c447c/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c447c/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c447b/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c447b/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c447a/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c447a/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4479/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4479/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4478/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4478/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4477/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4477/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4476/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4476/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4475/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4475/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4474/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4474/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4473/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4473/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4472/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4472/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4471/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4471/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4470/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4470/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c446f/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c446f/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c446e/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c446e/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c446d/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c446d/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c446c/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c446c/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c446b/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c446b/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c446a/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c446a/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4469/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4469/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4468/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4468/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4467/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4467/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4466/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4466/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4465/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4465/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4464/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4464/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4463/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4463/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4462/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4462/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4461/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4461/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4460/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4460/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c445f/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c445f/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c445e/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c445e/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c445d/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c445d/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c445c/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c445c/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c445b/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c445b/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c445a/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c445a/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4459/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4459/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4458/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4458/5e7e360dd1910400263c4456.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7e364ad1910400263c4457/5e7e360dd1910400263c4456.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7e364ad1910400263c4457/5e7e360dd1910400263c4456.png"}]

Keywords

keyword text

single guide RNA,sgRNA,RNA,ribonucleic acid,nucleic acid,guide RNA,cas9,crRNA,crisprRNA,trans-activating RNA,tracrrna,CRISPR associated protein 9,Clustered regularly interspaced short palindromic repeats,S. pyogenes,gRNA,stem loop

BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More

More Icons like this one in

Related Categories

Back To Library Home

Join 1,500,000 other scientists on BioRender

Sign up for your free account and start creating scientific figures faster today

Sign Up Free

FAQs

What is BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this SpCas9 sgRNA stem loop (medium) icon along with our library of more than 30,000 life science icons.

Can I use this icon in a BioRender figure or scientific illustration?

Yes, the SpCas9 sgRNA stem loop (medium) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the SpCas9 sgRNA stem loop (medium) icon customizable in BioRender?

Most icons in BioRender, including the SpCas9 sgRNA stem loop (medium) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

How are scientists using the SpCas9 sgRNA stem loop (medium) icon in their work?

BioRender users often use the SpCas9 sgRNA stem loop (medium) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Nucleic Acids.

Can I export figures that include the SpCas9 sgRNA stem loop (medium) icon for publication or presentations?

Yes, figures containing the SpCas9 sgRNA stem loop (medium) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

Is the SpCas9 sgRNA stem loop (medium) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the SpCas9 sgRNA stem loop (medium) icon — especially those focused on Nucleic Acids. You can search BioRender’s template library or add this icon manually to any canvas.

Make scientific figures in minutes

SpCas9 sgRNA stem loop (medium)

Join 1,500,000 other scientists on BioRender

FAQs

Looking for science content?